%0 Journal Article
%T Genetic variants of NOXA and MCL1 modify the risk of HPV16-associated squamous cell carcinoma of the head and neck
%A ZiYuan Zhou
%A Eric M Sturgis
%A ZhenSheng Liu
%A Li-E Wang
%A QingYi Wei
%A GuoJun Li
%J BMC Cancer
%D 2012
%I BioMed Central
%R 10.1186/1471-2407-12-159
%X HPV16 serology was obtained by immunoadsorption assay. Four functional SNPs in the promoter of NOXA (rs9957673, rs4558496) and MCL1 (rs9803935, rs3738485) were genotyped for 380 cases and 335 frequency-matched cancer-free controls of non-Hispanic whites.Associations between the four polymorphisms and SCCHN risk were not significant, while we observed a significantly joint effect on SCCHN risk between the polymorphisms and HPV16 seropositivity. Notably, this effect modification was particularly pronounced for oropharyngeal cancer in subgroups including never smokers, never drinkers and younger subjects.Our results suggested that polymorphisms of NOXA and MCL1 may modify the risk of HPV16-associated oropharyngeal cancer. The further identification of population subgroups at higher risk provides evidence that HPV-targeting treatment may help benefit SCCHN. However, larger studies are needed to validate our findings.
%K NOXA
%K MCL1
%K HPV16
%K Genetic susceptibility
%K Squamous cell carcinoma of the head and neck
%U http://www.biomedcentral.com/1471-2407/12/159/abstract